Lobbying Activity Report

2603-14590

Organization: Sandoz Canada Inc.
Associated registration: 2015-2603-10
Lobbying Activity date: 2021-11-16
Arranged a meeting: Yes
Posted date: 2021-12-10

In-house lobbyists who participated in the lobbying activity: Mauricio Ede-Filho Footnote1
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services &Evaluation
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

John Capelli, Executive Director, Pharmaceutical Policy, Legislation &Engagement
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

Mariana Diacu, Executive Director, Laboratory& Blood Services
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

Tijana Fazlagic, Executive Director, Therapeutic Assessment&Access
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

Derek Tryan, Executive coordinator, Pharmaceutical, Laboratory &Blood Services
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority

Kelly Uyeno, Executive Director, Integrated Health Services Planning&Systems
Pharmaceutical, Laboratory&Blood Services, Provincial Health Services Authority
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Improve regulatory environment and utilization rates for generics and biosimilars.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
Raising awareness to government officials for generic and biosimilar products development by Sandoz Canada Inc. and the potential savings realized by the healthcare system.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
 
Senior officer who filed this Lobbying Activity Report: Michel Robidoux
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: